Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Translation, Cultural Adaptation and Validation of the Hill Bone Compliance to High Blood Pressure Therapy Scale to Nepalese Language.

Tytuł:
Translation, Cultural Adaptation and Validation of the Hill Bone Compliance to High Blood Pressure Therapy Scale to Nepalese Language.
Autorzy:
Shakya R; Department of Nursing, Nobel College, Kathmandu, Province Bagmati, Nepal.
Shrestha R; Department of Pharmacy, District Hospital Lamjung, Lamjung, Province Gandaki, Nepal.
Shrestha S; School of Pharmacy, Monash University Malaysia, Subang Jaya, Selangor, Malaysia.
Sapkota P; Department of Nursing, Nobel College, Kathmandu, Province Bagmati, Nepal.
Gautam R; Department of Nursing, Tribhuvan University, Maharajgunj Nursing Campus, Kathmandu, Nepal.
Rai L; Department of Nursing, Tribhuvan University, Maharajgunj Nursing Campus, Kathmandu, Nepal.
Khatiwada AP; Department of Pharmaceutical and Health Service Research, Nepal Health Research and Innovation Foundation, Lalitpur, Province Bagmati, Nepal.
Ranabhat K; Center Department of Public Health, Institute of Medicine, Tribhuvan University, Maharajgunj, Kathmandu, Nepal.; Ministry of Health and Population, Kathmandu, Nepal.
Kc B; School of Pharmacy, Monash University Malaysia, Subang Jaya, Selangor, Malaysia.
Sapkota B; Department of Pharmaceutical Sciences, Nobel College, Affiliated to Pokhara University, Kathmandu, Province Bagmati, Nepal.
Khanal S; Division of Health Sciences, Warwick Medical School, University of Warwick, Coventry, UK.
Paudyal V; School of Pharmacy, Institute of Clinical Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
Źródło:
Patient preference and adherence [Patient Prefer Adherence] 2022 Apr 08; Vol. 16, pp. 957-970. Date of Electronic Publication: 2022 Apr 08 (Print Publication: 2022).
Typ publikacji:
Journal Article
Język:
English
Imprint Name(s):
Original Publication: [Auckland, N.Z.] : Dove Press Limited
References:
Eur Heart J Suppl. 2021 May 20;23(Suppl B):B110-B113. (PMID: 34054371)
J Clin Epidemiol. 2010 Mar;63(3):299-306. (PMID: 19762213)
Hypertension. 2020 Feb;75(2):285-292. (PMID: 31865786)
Rev Port Cardiol. 2016 Feb;35(2):93-7. (PMID: 26852304)
Prog Cardiovasc Nurs. 2000 Summer;15(3):90-6. (PMID: 10951950)
Int J Hypertens. 2021 Mar 02;2021:6610649. (PMID: 33747559)
Integr Blood Press Control. 2017 Jun 16;10:1-7. (PMID: 28670137)
Circ Res. 2019 Mar 29;124(7):984-986. (PMID: 30920927)
Patient Prefer Adherence. 2018 Apr 24;12:625-635. (PMID: 29731610)
Asian Nurs Res (Korean Soc Nurs Sci). 2011 Sep;5(3):183-8. (PMID: 25030368)
BMC Cardiovasc Disord. 2016 May 10;16:87. (PMID: 27165782)
Cardiovasc Drugs Ther. 2017 Dec;31(5-6):565-578. (PMID: 29032396)
Patient Prefer Adherence. 2012;6:613-22. (PMID: 22969292)
Rev Saude Publica. 2012 Apr;46(2):279-89. (PMID: 22331180)
Patient Prefer Adherence. 2020 Nov 20;14:2287-2300. (PMID: 33244224)
ARYA Atheroscler. 2016 Mar;12(2):76-86. (PMID: 27429627)
PLoS One. 2013 Apr 25;8(4):e62775. (PMID: 23638143)
J Nepal Health Res Counc. 2015 Jan-Apr;13(29):38-42. (PMID: 26411711)
Lancet. 2012 Aug 11;380(9841):611-9. (PMID: 22883510)
Lancet. 2012 Dec 15;380(9859):2224-60. (PMID: 23245609)
Hypertension. 2020 Jun;75(6):1334-1357. (PMID: 32370572)
Curr Opin Cardiol. 2004 Jul;19(4):357-62. (PMID: 15218396)
Patient Prefer Adherence. 2020 Oct 09;14:1853-1860. (PMID: 33116429)
J Nepal Health Res Counc. 2020 Jan 21;17(4):521-527. (PMID: 32001860)
Eur J Gen Pract. 2009 Dec;15(4):207-11. (PMID: 20055720)
Patient Prefer Adherence. 2021 Aug 27;15:1873-1885. (PMID: 34475753)
Malays Fam Physician. 2015 Aug 31;10(2):36-44. (PMID: 27099659)
Ethn Dis. 2006 Winter;16(1):286-91. (PMID: 16599385)
PLoS One. 2015 Aug 05;10(8):e0134834. (PMID: 26244512)
BMC Med Res Methodol. 2011 Nov 03;11:149. (PMID: 22050830)
PLoS Med. 2006 Nov;3(11):e442. (PMID: 17132052)
J Am Pharm Assoc (2003). 2011 Jan-Feb;51(1):90-4. (PMID: 21247831)
Hypertension. 2018 Aug;72(2):391-398. (PMID: 29915019)
Patient Prefer Adherence. 2017 Nov 28;11:1949-1956. (PMID: 29238170)
Contributed Indexing:
Keywords: Hill–Bone scale; Nepal; cultural adaptation; hypertension; translation; treatment adherence
Entry Date(s):
Date Created: 20220415 Latest Revision: 20220503
Update Code:
20240105
PubMed Central ID:
PMC9005151
DOI:
10.2147/PPA.S349760
PMID:
35422613
Czasopismo naukowe
Background: Control of high blood pressure and prevention of cardiovascular complications among hypertensive patients depends on patients' adherence to therapy. The Hill-Bone Compliance to High Blood Pressure Therapy Scale (HBCTS) is one of the most popular scale to assess hypertensive patients' adherence behaviour. Unfortunately, no questionnaire in the Nepalese language is available to date to assess adherence to anti-hypertensive therapy.
Aim: To translate, culturally adapt and validate the English original version of the HBCTS into Nepalese language to measure treatment adherence of Nepalese hypertensive patients.
Methods: The cross-sectional study was conducted to translate, culturally adapt and validate the HBCTS into Nepalese version. The standard translation process was followed and was evaluated among 282 hypertensive patients visiting selected primary healthcare centers (PHCCs) of Kathmandu district, Nepal. Cronbach's alpha was measured to assess the reliability of the tool. Exploratory factor analysis using principal component analysis with varimax rotation was used to evaluate structural validity.
Results: The mean±SD age of 282 participants was 58.49±12.44 years. Majority of participants were literate (75.2%), and consumed at least one anti-hypertensive medication per day (85.5%). Nearly half (42.2%) of the participants had a family history of hypertension, and almost half (48%) of them had comorbid conditions. Mean ±SD score for overall adherence was 17.85±3.87 while those of medication taking, reduced salt taking, and appointment keeping subscales were 10.63±2.55, 4.16±1.12 and 3.06±1.07, respectively. Kaiser Meyer Olkin (KMO) was found to be 0.877. Exploratory factor analysis revealed a three-component structure; however, the loading of components into medication adherence, reduced salt intake and appointment keeping constructs were not identical to the original tool. Cronbach's alpha score for the entire HBCTS scale was 0.846.
Conclusion: The translated Nepali version of the HBCTS demonstrated acceptable reliability and validity to measure adherence to antihypertensive therapy among hypertensive patients in clinical and community settings in Nepal.
Competing Interests: The authors declare that they have no conflicts of interest for this work.
(© 2022 Shakya et al.)
Zaloguj się, aby uzyskać dostęp do pełnego tekstu.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies